Rigel Pharmaceuticals Inc
(STU:RI2)
€
7.345
0 (0%)
Market Cap: 197.53 Mil
Enterprise Value: 207.64 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 72/100 Rigel Pharmaceuticals Inc (STU:RI2) Transcripts
- Q2 2024 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2024€7.35Earnings
- Q1 2024 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024€11.32 (+2.07%)Earnings
- Q4 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2024€13.48 (+1.35%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2023€7.69 (-0.57%)Earnings
- Rigel Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2023€12.32 (+3.92%)Earnings
- Rigel Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2023€10.22 (+1.90%)Earnings
- Q4 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 07, 2023€14.05 (-3.99%)Earnings
- Rigel Pharmaceuticals Inc To Discuss The FDA Approval of REZLIDHIA Call TranscriptDec 01, 2022
- Q3 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022€6.95 (+1.12%)Earnings
- Q2 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2022€11.53 (-1.11%)Earnings
- Rigel Pharmaceuticals Inc to Discuss FORWARD Study Results TranscriptJun 08, 2022
- Q1 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2022€23.01 (+2.72%)Earnings
- Q4 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022€22.23 (+0.82%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2021€30.21 (+1.51%)Earnings
- Rigel Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021€31.32 (-6.92%)Earnings
- Rigel Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 18, 2021
- Q1 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021€28.5 (+0.96%)Earnings
- Rigel Pharmaceuticals Inc Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19 -Corporate Call TranscriptApr 13, 2021
- Q4 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 02, 2021€36.6 (+3.39%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020€23.2 (+3.57%)Earnings
- Rigel Pharmaceuticals Inc at Citi BioPharma Conference (Virtual)- Panel: State of Play for COVID-19 Therapeutics TranscriptSep 09, 2020
- Q2 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2020€19.8 (+3.13%)Earnings
- Rigel Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 14, 2020
- Q1 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2020€17.5 (+6.06%)Earnings
- Q4 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2020€19.5 (-0.51%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019€19 (-2.06%)Earnings
- Rigel Pharmaceuticals Inc Investor and Analyst Call TranscriptOct 23, 2019
- Editas Medicine Inc, Apellis Pharmaceuticals Inc and Rigel Pharmaceuticals Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019€18.72 (+1.24%)Earnings
- Q1 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2019€20.97 (+2.24%)Earnings
- Q4 2018 Rigel Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2019€19.5 (+1.04%)Earnings
- 1